MDS research criteria for prodromal Parkinson's disease. - Wikidata - wikimedia - TriplyDB

MDS research criteria for prodromal Parkinson's disease.

MDS research criteria for prodromal Parkinson's disease.

http://www.wikidata.org/entity/Q34498279

about

Emerging approaches in Parkinson's disease - adjunctive role of safinamide Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease The prediagnostic phase of Parkinson's disease Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease Environmental Exposures and Parkinson's Disease Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder The gut microbiome in human neurological disease: A review.Non-motor symptoms and quality of life in subjects with mild parkinsonian signs.Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.Striatal and Hippocampal Atrophy in Idiopathic Parkinson's Disease Patients without Dementia: A Morphometric Analysis.Neuroimaging in pre-motor Parkinson's disease Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism.Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects Imaging Parkinson's disease below the neck.Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease MDS clinical diagnostic criteria for Parkinson's disease.Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.Recent advances in treating Parkinson's disease.Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers."Gunslinger's gait": a new cause of unilaterally reduced arm swing.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Inflammatory profile in LRRK2-associated prodromal and clinical PD Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.Natural history of pure autonomic failure: A United States prospective cohort PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.Associations between Early Markers of Parkinson's Disease and Sarcopenia.The Synucleinopathies: Twenty Years On.Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's disease.The Concept of Prodromal Parkinson's Disease.Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD.

P2860

Q26740905-5AC2D897-1386-450B-8C34-9C13D8C37941 Q26748711-CB8226E5-CA38-460B-8A43-58F09015BBB9 Q26768732-B875B746-19C1-4DE7-8088-CB4ED2CA8670 Q28071861-0002DA07-008E-471F-BB56-9E121886084B Q28074723-091F3B54-F235-4A57-943B-3743C9F6BB68 Q28553194-7E3B2EC8-0614-461B-BC6B-47D3E4E09495 Q29048624-FC5C827D-3E30-4BB6-864E-02C8877187CE Q30356478-82CC6057-2DFA-4B04-8F3E-3985D33CD0E8 Q30490923-E8CC7A45-060A-4716-B25B-C9879AEC1E41 Q30572455-6484F6AC-3D2E-445A-8413-F830FBB9D6DE Q30841744-A865493A-5F4E-4FAE-97D7-3683DDDBAE4C Q33559200-0E5DC4BC-6A19-44DB-B186-8412640010CD Q33676222-FE04A638-A9F0-458B-9F2A-C35C871A619E Q33708957-4C40A4D5-D59F-4136-960C-6C91A51D00F5 Q33731267-82A94038-4DCB-4B56-9CAA-E245A4FE7ADE Q33734084-2AC761F4-2976-4B70-BB08-CE6E0440F909 Q33767061-FB1DC077-3DBC-448D-9DBE-B83DCF43B6A7 Q33861898-04BA9B58-34D4-44BD-957C-2FAEA644404C Q33905821-FB93297C-D5EF-4CB1-B9A5-0E3F0D04F657 Q34498274-504C1348-B8EA-44C4-A40F-07B2CA403898 Q34550489-02BA0334-58D0-447C-92E7-89BF5EB22AB6 Q34554401-49D56AF4-DF18-4808-845F-91EBBA3109E6 Q36092538-84D0956B-53F3-4A6E-A602-4FEF4C96F2A5 Q36345908-38C52000-BB2D-4399-A4CD-C1B1CE5749B8 Q36369299-81734E16-B621-406B-A2B1-13FABFAF6B94 Q36374541-06AB1AAB-D1BD-46C7-ACD4-5D9A1A162F6C Q36934387-CEEA9B07-4E98-49AB-9AAC-DFB9B44612E5 Q36946063-2B953125-60DA-4F99-BF14-1AD484A262E4 Q37054007-FA1604AE-602D-436A-BF47-F2FEBBB3F21C Q37129119-695E9753-34A7-4183-B1A8-2A21F57082F4 Q37548320-5BE81A5D-06E1-4DF8-9C52-7D22FAA3BB1F Q37662455-92634710-06F7-476D-A92D-D8CAA0F4F7E0 Q37663889-B7DF4C9E-7C9D-4386-9F7D-C2352857C38A Q37683074-17D232BD-2599-4AC0-B597-3336F7931D65 Q37693375-131C4C9F-3094-4E83-AE57-0EF93285DC8D Q38384109-6E5950CB-107B-43E9-9AAE-F690C64F1A22 Q38601317-18117586-844A-4E9C-B707-ADF72C1B191F Q38612230-422E8D8C-37FD-44FD-A5EF-9A4DF37D8078 Q38666247-A4CB2EFD-7A7B-4B49-9D8D-798D4CA51216 Q38702118-5AF40D2D-B14C-4517-A495-638F4C7A692C

P2860

MDS research criteria for prodromal Parkinson's disease.

http://www.wikidata.org/entity/Q34498279

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

MDS research criteria for prodromal Parkinson's disease.

@ast

MDS research criteria for prodromal Parkinson's disease.

@en

MDS research criteria for prodromal Parkinson's disease.

@nl

type

label

MDS research criteria for prodromal Parkinson's disease.

@ast

MDS research criteria for prodromal Parkinson's disease.

@en

MDS research criteria for prodromal Parkinson's disease.

@nl

prefLabel

MDS research criteria for prodromal Parkinson's disease.

@ast

MDS research criteria for prodromal Parkinson's disease.

@en

MDS research criteria for prodromal Parkinson's disease.

@nl

P1433

Q34498279-0078B681-35FD-49F4-8D2A-DB01817212CD

P1476

Q34498279-FF1CFE32-A63C-4BCE-ADCA-41505FC40C2E

P2093

Q34498279-0D3A1213-8D42-45DF-85FA-317E088FD54E

Q34498279-1F14006F-B6D7-4DA5-80ED-1C77A3199CCE

Q34498279-65C9A18B-A1F7-4574-8B65-C1519016A027

Q34498279-AAA4128F-01E7-474D-97DD-C808726D0A79

Q34498279-D94FE657-86B4-43AD-A428-032825ECCA5C

Q34498279-E323F036-D0B6-4C79-AAB0-EC86BA4EEE6B

P2860

Q34498279-01876595-8FEA-43F9-BDED-00370E2AC7EA

Q34498279-03C202B9-9A60-49ED-BD87-E7E8D58A4AEF

Q34498279-074B59A5-3B1C-4587-929A-5F360B415CFC

Q34498279-083BF9D4-F781-48C7-AEA7-5E718F05D121

Q34498279-0A0AB4AD-5A66-4D6E-8EB3-D9DDD27D13CA

Q34498279-0C3ACD00-F685-4EB0-9F2A-BAE760F2AD83

Q34498279-0C3CE3F2-BE54-4AC1-9FFB-643FF275C613

Q34498279-0F7A5445-53BD-4609-9073-AC08FCED29D0

Q34498279-1636F926-8EDF-48AD-850C-64EEBCDA00F7

Q34498279-1C37EF1B-5C91-4957-8CA5-79F676E1BC8D

P304

Q34498279-1E4EE672-CE21-4ACA-A053-AC314F70C64D

P31

Q34498279-F7FFBF68-CF02-4CC2-ABE7-536DC9DB3D4A

P356

Q34498279-BFF422C8-A9CB-4CBB-80A6-729AEB45BFCB

P407

Q34498279-BB331280-D8C0-4586-A364-B7ECBE7468F5

P433

Q34498279-D4007775-4389-4C1A-B284-BEDAC18258DD

P478

Q34498279-AD90E4C7-B7FC-48B8-B356-00735897FF30

P50

Q34498279-1B5BB71F-A727-48E8-A638-F0876F5BEA99

Q34498279-258B7D52-F0A0-4225-B206-4EBDE6682657

Q34498279-3CF371E7-5638-4773-9711-3DB616693ACE

Q34498279-42117339-9F3D-4B64-A160-D183A8E3A656

Q34498279-48D9BD5C-AFE9-471F-A92D-1882F17F2196

Q34498279-5B4945F7-29F7-4235-90F1-EF9D2557441A

Q34498279-72F32A85-3E0A-4F86-ABE4-9682209181A6

Q34498279-92DD3FDE-C864-466B-BD12-930B94D6B872

Q34498279-9885020E-E829-4006-96D2-63AE22E032B3

Q34498279-9BDF6AA3-A562-45DA-8422-10B127BC5E70

P577

Q34498279-4A05130C-F50E-4517-BC04-AEF16A5BE831

P5875

Q34498279-AAE93883-E53F-41AC-B998-4BC761B5F312

P698

Q34498279-ACFCCA9E-557F-4B70-9A17-00EFC06BE20F

P921

Q34498279-CD521DA3-95A5-4E78-A45B-61155C930E9F

P356

P1433

Movement Disorders

P1476

MDS research criteria for prodromal Parkinson's disease.

@en

P2093

José Obeso

http://www.w3.org/2001/XMLSchema#string

Kenneth Marek

http://www.w3.org/2001/XMLSchema#string

Lawrence Joseph

http://www.w3.org/2001/XMLSchema#string

Matthew Stern

http://www.w3.org/2001/XMLSchema#string

Piu Chan

http://www.w3.org/2001/XMLSchema#string

Ronald B Postuma

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Epidemiology of Parkinson's disease

Frequency of bowel movements and the future risk of Parkinson's disease.

Excessive daytime sleepiness and subsequent development of Parkinson disease.

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.

Transcranial sonography in movement disorders.

Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study.

Defining at-risk populations for Parkinson's disease: lessons from ongoing studies.

Individual and joint prevalence of three nonmotor symptoms of PD in the US general population

P304

1600-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.26431

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Inga Liepelt-Scarfone

Günther Deuschl

Glenda Halliday

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282910852

http://www.w3.org/2001/XMLSchema#string

P698

26474317

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease